Protagenic Therapeutics, Inc. (PTIX)

$0.59

+0.01 (+2.13%)
Rating:
Recommendation:
-
Symbol PTIX
Price $0.59
Beta 0.057
Volume Avg. 0.03M
Market Cap 10.198M
Shares () -
52 Week Range 0.33-1.23
1y Target Est -
DCF Unlevered PTIX DCF ->
DCF Levered PTIX LDCF ->
ROE -44.83% Strong Sell
ROA -46.58% Strong Sell
Operating Margin -
Debt / Equity 11.82% Neutral
P/E -
P/B 1.38 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PTIX news


Dr. Garo H. Armen
Healthcare
Biotechnology
NASDAQ Capital Market

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.